ZYNEX INC (ZYXI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ZYXI • US98986M1036

0.125 USD
-0.07 (-34.9%)
At close: Dec 23, 2025
0.13 USD
+0.01 (+4%)
After Hours: 12/23/2025, 8:00:03 PM
Fundamental Rating

2

Overall ZYXI gets a fundamental rating of 2 out of 10. We evaluated ZYXI against 186 industry peers in the Health Care Equipment & Supplies industry. ZYXI may be in some trouble as it scores bad on both profitability and health. ZYXI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ZYXI has reported negative net income.
  • In the past year ZYXI has reported a negative cash flow from operations.
  • In the past 5 years ZYXI has always been profitable.
  • ZYXI had a positive operating cash flow in each of the past 5 years.
ZYXI Yearly Net Income VS EBIT VS OCF VS FCFZYXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

1.2 Ratios

  • With a Return On Assets value of -163.18%, ZYXI is not doing good in the industry: 88.17% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -163.18%
ROE N/A
ROIC N/A
ROA(3y)8.05%
ROA(5y)9.92%
ROE(3y)18.36%
ROE(5y)18.84%
ROIC(3y)N/A
ROIC(5y)N/A
ZYXI Yearly ROA, ROE, ROICZYXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • ZYXI's Profit Margin has declined in the last couple of years.
  • ZYXI's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 71.90%, ZYXI belongs to the best of the industry, outperforming 81.18% of the companies in the same industry.
  • ZYXI's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ZYXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.9%
OM growth 3Y-43.42%
OM growth 5Y-33.75%
PM growth 3Y-50.87%
PM growth 5Y-40.5%
GM growth 3Y0.14%
GM growth 5Y-0.29%
ZYXI Yearly Profit, Operating, Gross MarginsZYXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • ZYXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ZYXI has less shares outstanding
  • ZYXI has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZYXI is higher compared to a year ago.
ZYXI Yearly Shares OutstandingZYXI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ZYXI Yearly Total Debt VS Total AssetsZYXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -2.75, we must say that ZYXI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.75, ZYXI is doing worse than 63.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.75
ROIC/WACCN/A
WACC4.78%
ZYXI Yearly LT Debt VS Equity VS FCFZYXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.47 indicates that ZYXI may have some problems paying its short term obligations.
  • The Current ratio of ZYXI (0.47) is worse than 91.94% of its industry peers.
  • ZYXI has a Quick Ratio of 0.47. This is a bad value and indicates that ZYXI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ZYXI (0.32) is worse than 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.32
ZYXI Yearly Current Assets VS Current LiabilitesZYXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for ZYXI have decreased strongly by -540.63% in the last year.
  • ZYXI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.77% yearly.
  • ZYXI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.13%.
  • Measured over the past years, ZYXI shows a very strong growth in Revenue. The Revenue has been growing by 33.42% on average per year.
EPS 1Y (TTM)-540.63%
EPS 3Y-41.04%
EPS 5Y-18.77%
EPS Q2Q%-671.43%
Revenue 1Y (TTM)-44.13%
Revenue growth 3Y13.86%
Revenue growth 5Y33.42%
Sales Q2Q%-73.26%

3.2 Future

  • Based on estimates for the next years, ZYXI will show a very negative growth in Earnings Per Share. The EPS will decrease by -28.28% on average per year.
  • Based on estimates for the next years, ZYXI will show a decrease in Revenue. The Revenue will decrease by -7.81% on average per year.
EPS Next Y-1584.67%
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%
EPS Next 5Y-28.28%
Revenue Next Year-52.33%
Revenue Next 2Y-27.82%
Revenue Next 3Y-15.7%
Revenue Next 5Y-7.81%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZYXI Yearly Revenue VS EstimatesZYXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
ZYXI Yearly EPS VS EstimatesZYXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • ZYXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ZYXI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZYXI Price Earnings VS Forward Price EarningsZYXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZYXI Per share dataZYXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • A cheap valuation may be justified as ZYXI's earnings are expected to decrease with -60.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ZYXI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZYNEX INC

NASDAQ:ZYXI (12/23/2025, 8:00:03 PM)

After market: 0.13 +0.01 (+4%)

0.125

-0.07 (-34.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-17
Earnings (Next)03-09
Inst Owners13.71%
Inst Owner Change-25.26%
Ins Owners47.94%
Ins Owner Change0%
Market Cap3.80M
Revenue(TTM)108.20M
Net Income(TTM)-73.96M
Analysts82.5
Price Target2.91 (2228%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)-65.69%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-176.55%
Min EPS beat(2)-229.01%
Max EPS beat(2)-124.09%
EPS beat(4)0
Avg EPS beat(4)-127.42%
Min EPS beat(4)-229.01%
Max EPS beat(4)-34.8%
EPS beat(8)2
Avg EPS beat(8)-77.04%
EPS beat(12)6
Avg EPS beat(12)-26.42%
EPS beat(16)9
Avg EPS beat(16)-20.44%
Revenue beat(2)0
Avg Revenue beat(2)-31.63%
Min Revenue beat(2)-43.09%
Max Revenue beat(2)-20.18%
Revenue beat(4)0
Avg Revenue beat(4)-23.68%
Min Revenue beat(4)-43.09%
Max Revenue beat(4)-15.48%
Revenue beat(8)0
Avg Revenue beat(8)-15.48%
Revenue beat(12)1
Avg Revenue beat(12)-10.53%
Revenue beat(16)1
Avg Revenue beat(16)-8.43%
PT rev (1m)0%
PT rev (3m)-37.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.43%
EPS NY rev (1m)0%
EPS NY rev (3m)0.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS3.56
BVpS-1.36
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -163.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.9%
FCFM N/A
ROA(3y)8.05%
ROA(5y)9.92%
ROE(3y)18.36%
ROE(5y)18.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.93%
ROCE(5y)15.14%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.42%
OM growth 5Y-33.75%
PM growth 3Y-50.87%
PM growth 5Y-40.5%
GM growth 3Y0.14%
GM growth 5Y-0.29%
F-Score4
Asset Turnover2.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.44%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.32
Altman-Z -2.75
F-Score4
WACC4.78%
ROIC/WACCN/A
Cap/Depr(3y)18.03%
Cap/Depr(5y)28.76%
Cap/Sales(3y)0.41%
Cap/Sales(5y)0.58%
Profit Quality(3y)218.02%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-540.63%
EPS 3Y-41.04%
EPS 5Y-18.77%
EPS Q2Q%-671.43%
EPS Next Y-1584.67%
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%
EPS Next 5Y-28.28%
Revenue 1Y (TTM)-44.13%
Revenue growth 3Y13.86%
Revenue growth 5Y33.42%
Sales Q2Q%-73.26%
Revenue Next Year-52.33%
Revenue Next 2Y-27.82%
Revenue Next 3Y-15.7%
Revenue Next 5Y-7.81%
EBIT growth 1Y-519.9%
EBIT growth 3Y-35.57%
EBIT growth 5Y-11.61%
EBIT Next Year-252.95%
EBIT Next 3Y-38.41%
EBIT Next 5Y-9.53%
FCF growth 1Y-234.51%
FCF growth 3Y24.19%
FCF growth 5Y14.61%
OCF growth 1Y-225.94%
OCF growth 3Y22.32%
OCF growth 5Y15.09%

ZYNEX INC / ZYXI FAQ

What is the ChartMill fundamental rating of ZYNEX INC (ZYXI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ZYXI.


What is the valuation status for ZYXI stock?

ChartMill assigns a valuation rating of 0 / 10 to ZYNEX INC (ZYXI). This can be considered as Overvalued.


What is the profitability of ZYXI stock?

ZYNEX INC (ZYXI) has a profitability rating of 3 / 10.


What is the expected EPS growth for ZYNEX INC (ZYXI) stock?

The Earnings per Share (EPS) of ZYNEX INC (ZYXI) is expected to decline by -1584.67% in the next year.


Can you provide the dividend sustainability for ZYXI stock?

The dividend rating of ZYNEX INC (ZYXI) is 0 / 10 and the dividend payout ratio is 0%.